Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/26/24
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 06/21/23
End: 03/31/39
Due: 03/31/40
Phase: N/A
Priority: Normal
Start: 03/03/23
End: 08/31/25
Due: 08/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia | NCT06433557 | Ascendis Pharma Growth Disorders A/S | user2@example.com | None | 2024-07-26 | 2027-09-30 | 2028-09-30 | - | - | 2025-07-14 |
| A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia | NCT05929807 | Ascendis Pharma Growth Disorders A/S | user2@example.com | None | 2023-06-21 | 2039-03-31 | 2040-03-31 | - | - | 2025-07-14 |
| A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia | NCT05598320 | Ascendis Pharma Growth Disorders A/S | user2@example.com | None | 2023-03-03 | 2025-08-31 | 2026-08-31 | - | - | 2025-07-14 |